Total Payments
$8,231
2024 Payments
$2,471
Companies
55
Transactions
508
Medicare Patients
3,870
Medicare Billing
$409,728
Payment Breakdown by Category
Food & Beverage$8,078 (98.1%)
Consulting$150.00 (1.8%)
Education$3.87 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,078 | 506 | 98.1% |
| Consulting Fee | $150.00 | 1 | 1.8% |
| Education | $3.87 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,558 | 111 | $0 (2024) |
| Lilly USA, LLC | $647.22 | 51 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $546.01 | 29 | $0 (2022) |
| UCB, Inc. | $489.64 | 37 | $0 (2024) |
| Amgen Inc. | $427.28 | 27 | $0 (2024) |
| Lundbeck LLC | $364.99 | 16 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $342.81 | 21 | $0 (2024) |
| Eisai Inc. | $323.19 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $291.44 | 22 | $0 (2023) |
| PFIZER INC. | $277.37 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,471 | 145 | ABBVIE INC. ($722.27) |
| 2023 | $1,484 | 90 | AbbVie Inc. ($458.06) |
| 2022 | $1,233 | 90 | ABBVIE INC. ($361.27) |
| 2021 | $12.08 | 1 | Lilly USA, LLC ($12.08) |
| 2020 | $371.96 | 22 | Amgen Inc. ($61.82) |
| 2019 | $868.60 | 63 | Novartis Pharmaceuticals Corporation ($182.67) |
| 2018 | $952.06 | 53 | Supernus Pharmaceuticals, Inc. ($241.81) |
| 2017 | $838.38 | 44 | Alkermes, Inc. ($150.00) |
All Payment Transactions
508 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/18/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/13/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Adenosine A2A Receptors | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Rare Disease | ||||||
| 11/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: Immunology and Neurology | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Neurology | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/31/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/30/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 667 | 772 | $239,591 | $59,402 |
| 2022 | 12 | 840 | 1,044 | $298,225 | $82,070 |
| 2021 | 14 | 1,199 | 1,701 | $454,871 | $139,207 |
| 2020 | 16 | 1,164 | 1,673 | $435,600 | $129,048 |
Total Patients
3,870
Total Services
5,190
Medicare Billing
$409,728
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 183 | $50,508 | $14,727 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $53,760 | $13,047 | 24.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 138 | 204 | $51,204 | $12,647 | 24.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 50 | 50 | $32,300 | $7,486 | 23.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 77 | 77 | $31,339 | $7,087 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 17 | $4,692 | $1,015 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $5,460 | $986.10 | 18.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 18 | 18 | $2,970 | $671.52 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,916 | $666.60 | 22.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 18 | 19 | $3,116 | $648.27 | 20.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 50 | 51 | $1,326 | $420.62 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 245 | $64,448 | $19,636 | 30.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 148 | 219 | $52,341 | $14,416 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 115 | 115 | $46,000 | $12,529 | 27.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 64 | 64 | $39,360 | $10,263 | 26.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 80 | 83 | $32,204 | $8,048 | 25.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 82 | $14,596 | $4,412 | 30.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $15,500 | $4,291 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 38 | $10,007 | $2,439 | 24.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 37 | 44 | $6,864 | $1,795 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $6,800 | $1,516 | 22.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,707 | $1,056 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $2,695 | $903.23 | 33.5% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 11 | 13 | $2,028 | $566.49 | 27.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 63 | 67 | $1,675 | $198.36 | 11.8% |
About Dr. Michael Chen, DO
Dr. Michael Chen, DO is a Neurology healthcare provider based in Council Bluffs, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205859170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Chen, DO has received a total of $8,231 in payments from pharmaceutical and medical device companies, with $2,471 received in 2024. These payments were reported across 508 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($8,078).
As a Medicare-enrolled provider, Chen has provided services to 3,870 Medicare beneficiaries, totaling 5,190 services with total Medicare billing of $409,728. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Council Bluffs, IA
- Active Since 07/25/2006
- Last Updated 12/17/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1205859170
Products in Payments
- UBRELVY (Drug) $787.34
- QULIPTA (Drug) $699.47
- EMGALITY (Drug) $585.72
- Briviact (Drug) $400.35
- Aimovig (Biological) $385.68
- NURTEC ODT (Drug) $368.37
- NUPLAZID (Drug) $342.81
- OXTELLAR XR (Drug) $300.16
- GOCOVRI (Drug) $270.01
- TROKENDI XR (Drug) $245.85
- VYEPTI (Biological) $195.83
- Leqembi (Drug) $178.94
- ONFI (Drug) $141.27
- Solitaire (Device) $136.33
- Fycompa (Drug) $124.23
- AIMOVIG (Biological) $112.85
- ACTHAR (Biological) $103.30
- WAKIX (Drug) $101.37
- FYCOMPA (Drug) $100.01
- AUBAGIO (Drug) $94.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.